Areas of focus will include identifying age-related changes that impact the development, progression and experience of Alzheimer’s and related dementias, and how factors that arise in early- and mid-life contribute to racial, ethnic and geographic disparities in dementia.
The Division of Neuromuscular Disorders has been designated as a GBS|CIDP Foundation International Center of Excellence for the diagnosis and treatment of Guillain-Barre Syndrome, Chronic Inflammatory Demyelinating Polyneuropathy, and other inflammatory peripheral neuropathies.
Second-year Adult Neurology resident Dr. Laura de Lima Xavier received the award during the 2021 UNC School of Medicine’s Whitehead Lecture and Awards ceremony on August 4.
Learn about aducanumab and UNC Neurology’s position on the new drug approved by the FDA for Alzheimer’s disease.
Jorge L. Almodóvar-Suárez, MD, associate professor of general neurology and neuromuscular disorders, is the new director of the UNC Department of Neurology’s Amyotrophic Lateral Sclerosis (ALS) Clinic. Born and raised in Puerto Rico, Dr. Almodóvar-Suárez is graduate of the state-funded University of Puerto Rico System, and a faithful believer of education and health care for … Read more
The UNC Department of Neurology is proud to announce that UNC neurologists Clio Rubinos, MD, MS, and Miriam Sklerov, MD, MS, have both received UNC School of Medicine Physician Scientist Training Program Faculty Awards.
The Duke/UNC Alzheimer’s Disease Research Collaborative is offering $50,000 Norins pilot awards to stimulate and support collaborative, innovative research on the potential role of microbes or pathogens in the development of Alzheimer’s disease. The principal investigator must be a Duke University faculty member or postdoctoral fellow, but cross-disciplinary and cross-institutional collaborations is strongly encouraged.
Over 800 scientists from across the United States and overseas convened virtually for a joint Duke/UNC Alzheimer’s Disease Symposium on May 27.
